Skip to content

Evaluation of the Efficacy of Acupuncture Combined With Intermittent Catheterization for Postoperative Urinary Retention Due to Neurogenic Bladder Following Radical Hysterectomy for Cervical Cancer

Evaluation of the Efficacy of Acupuncture Combined With Intermittent Catheterization for Postoperative Urinary Retention Due to Neurogenic Bladder Following Radical Hysterectomy for Cervical Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001427
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-06-15
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative urinary retention

Interventions

Acupuncture Group:Participants receive acupuncture treatment in addition to intermittent catheterization and an a-blocker (e.g., tamsulosin).
Sham-Acupuncture Group:Participants receive sham acupuncture treatment in addition to intermittent catheterization and an a-blocker (e.g., tamsulosin).

Sponsors

Obstetrics & Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.?Patients with a pathologically confirmed diagnosis of cervical cancer who have undergone radical hysterectomy for cervical cancer. 2.Patients who developed urinary retention after catheter removal during routine postoperative follow-up , with post-void residual urine volume measured by ultrasound exceeding 100 ml on two consecutive occasions. 3.Aged =18 years. 4.?Patients who are informed and voluntarily sign the informed consent form. 5.Patients with a Karnofsky Performance Status (KPS) score =70 .

Exclusion criteria

Exclusion criteria: 1.Patients with a clear preoperative diagnosis of urinary retention or voiding dysfunction. 2.Patients with urinary retention caused by conditions other than radical surgery for cervical cancer, such as spinal cord injury or other diseases. 3.Patients with severe heart, lung, or kidney failure, or those with severe medical comorbidities. 4.Patients with a severe bleeding tendency due to any cause. 5.Patients with severe consciousness disorders or psychiatric/psychological conditions that preclude cooperation with treatment.

Design outcomes

Primary

MeasureTime frame
?Post-void residual urine volume (PVR);

Secondary

MeasureTime frame
Voiding diary;Maximum urinary flow rate (Qmax);First desire to void (FDV);Maximum Cystometric Capacity;Simplified version of the ICIQ-FLUTS score;

Countries

China

Contacts

Public ContactJiang Hua

Obstetrics & Gynecology Hospital of Fudan University

jianghua1231@fckyy.org.cn+86 21 3318 9900

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026